DOCSLIB.ORG

Abstracts Monday August 26

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abstracts Monday August 26 ABSTRACTS MONDAY AUGUST 26 KEYNOTES, SYMPOSIA, ORAL PRESENTATION SESSIONS, POSTER DISCUSSION SESSIONS, THEMATIC POSTER SESSIONS “On Air Table of contents Monday August 26, 9:00 AM – 10:00 AM ............................................................................................... 23 Keynote Lectures .................................................................................................................................. 23 Cities as unequal opportunities for good health ........................................................................................... 23 Challenges and Prospects of Environmental Epidemiology in Africa ............................................................ 24 Monday August 26 10:30 AM – 12:00 PM .............................................................................................. 25 S01: Mapping the Air Pollution Metabolome: Applications, Limitations, and the Path Forward ............... 25 Metabolic perturbations following exposures to traffic-related air pollution in a panel of commuters with and without asthma ...................................................................................................................................... 25 Traffic-Related Air Pollution Exposure and Altered Fatty Acid Oxidation Among Adolescents and Young Adults – the Interplay with Obesity .............................................................................................................. 26 The Maternal Serum Metabolome and Ambient Air Pollution Exposure during Pregnancy ........................ 27 High-resolution metabolomics in human clinical studies of traffic-related pollutants ................................ 28 Changes in the blood metabolome in relation to air pollution exposure: results from the EXPOsOMICS project ........................................................................................................................................................... 29 S03: One Health: On animals, humans and the environment .................................................................. 30 The One Health Approach: Perspectives for Environmental Epidemiology.................................................. 30 Field evaluation of air sampling methods using a one-health approach to assess pathogen contamination in animal operation environments ................................................................................................................ 32 On Places-I: Emerging exposures and health effects in the farm environment ........................................... 33 On Places-II: Emerging Exposures and Health Effects in the Hospital Environment .................................... 34 S05: PFAS Research Reaches its Adolescence: What Have We Learned and Where Are We Going? .......... 35 Perils of biomarkers of exposure vs. external exposure estimates: Lessons from the mid-Ohio Valley on potential for reverse causality and other biases ........................................................................................... 35 Approaches to Integrating the Toxicology and Epidemiology Evidence on PFAS ......................................... 36 PFAS Dose Response Relationships and New Research Strategies ............................................................... 37 Evolution of Research on Health Effects of PFAS and Current Unmet Needs to Inform Public Policy ......... 38 S20: A world less dependent on fossil fuels – scientific evidence and corporate influence. An ISEE Policy Committee Symposium ......................................................................................................................... 39 Introduction to the symposium .................................................................................................................... 39 The Impact of Fossil Fuel Combustion on Global Health .............................................................................. 40 Health impact of China Coal Consumption Cap Project: an analysis of PM2.5 monitoring and morbidity/mortality data in typical cities in China ........................................................................................ 41 The world is unequal: The energy dilemma in LMICs ................................ ................................................... 42 Policies for accelerating progress towards a fossil fuel free economy and improving health...................... 43 OPS 01: Understudied environmental health issues ............................................................................... 44 1 Association of urinary metabolites of organophosphate flame retardants with chronic kidney function markers in the US general population .......................................................................................................... 44 Biomarker-Based Assessment of the Influence of Chemical Exposures on Chronic Kidney Disease ............ 45 Prenatal exposure to perfluoroalkyl substances and child liver injury ......................................................... 46 Tampon use, environmental chemicals and oxidative stress ....................................................................... 47 Accounting for intercourse in the relationship of ambient temperature with fecundability ....................... 48 Health impact of attending school close to the abandoned copper mine of Musoshi, DR Congo ............... 49 OPS 10: Wildfires .................................................................................................................................. 50 Mortality in US In-Center Hemodialysis Patients Following Exposure to Wildfire Smoke PM2.5 ................ 50 Extreme heat episodes, wildfires, and risk of preterm delivery in California, 2005-2013 ............................ 51 Characterizing Impacts of Wildfire Smoke Exposure on Medication Fills and Outpatient Visits for Asthma during the 2015 Wildfire Season in the Western United States ................................................................... 52 Out-of-Hospital Cardiac Arrests and Fine Particulate Matter (PM2.5) during 2015-2017 California Wildfires ....................................................................................................................................................................... 53 Wildfire smoke may interfere with the use of black carbon as an indicator of traffic exposure ................. 54 Development of Land-Use Regression Models for Particulate Matter due to residential wood burning in Temuco, Chile ................................................................................................................................................ 55 OPS 15: Chemicals and pregnancy ......................................................................................................... 56 Risk of congenital anomalies near municipal waste incinerators in England and Scotland: retrospective population-based cohort study ..................................................................................................................... 56 Associations of prenatal urinary phthalates, gestational weight gain, and postpartum weight retention among pregnant women from Mexico City .................................................................................................. 57 Per- and polyfluoroalkyl substances in early pregnancy and risk for preeclampsia ..................................... 58 Associations between urinary parabens exposure in early to mid-pregnancy and gestational diabetes mellitus .......................................................................................................................................................... 59 Parameters of ovarian reserve in relation to urinary concentrations of parabens ...................................... 60 No association between perfluorinated compounds and preeclampsia in the highly exposed population of Ronneby, Sweden .......................................................................................................................................... 61 OPS 25: Drinking water contamination and adult health ........................................................................ 62 Assessment of drinking water safety in the Netherlands using nationwide exposure and mortality data .. 62 Arsenic and disinfection by-products (DBPs) in drinking water in Canada: a population-based study to explore any association with relevant cancers. ............................................................................................ 63 Long-term exposure to widespread drinking water chemicals, blood inflammation markers and colorectal cancer ............................................................................................................................................................ 64 Ulcerative colitis, Crohn’s disease and other inflammatory bowel disease in a population with high exposure to per- and polyfluoroalkyl substances through drinking water ................................................... 65 Half-lives of PFOA, PFPeS, PFHxS, PFHpS and PFOS after end of exposure to contaminated drinking water ....................................................................................................................................................................... 66 Chronic Kidney Disease of undetermined cause (CKDu), an emerging disease in developing nations: a Malawian geographical study with focus on potable water sources ............................................................ 67 2 OPS 45: Cardiometabolic effects of
Load more

Recommended publications
  • Chemicals in the Fourth Report and Updated Tables Pdf Icon[PDF
    Chemicals in the Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, March 2021 CDC’s Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, March 2021 provides exposure data on the following chemicals or classes of chemicals. The Updated Tables contain cumulative data from national samples collected beginning in 1999–2000 and as recently as 2015-2016. Not all chemicals were measured in each national sample. The data tables are available at https://www.cdc.gov/exposurereport. An asterisk (*) indicates the chemical has been added since publication of the Fourth National Report on Human Exposure to Environmental Chemicals in 2009. Adducts of Hemoglobin Acrylamide Formaldehyde* Glycidamide Tobacco Alkaloids and Metabolites Anabasine* Anatabine* Cotinine Cotinine-n-oxide* Hydroxycotinine* Trans-3’-hydroxycotinine* 1-(3-Pyridyl)-1-butanol-4-carboxylic acid* Nicotine* Nicotine-N’-oxide* Nornicotine* Tobacco-Specific Nitrosamines (TSNAs) N’-Nitrosoanabasine (NAB)* N’-Nitrosoanatabine (NAT)* N’-Nitrosonornicotine (NNN)* Total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL)* Volatile N-nitrosamines (VNAs) N-Nitrosodiethylamine (NDEA)* N-Nitrosoethylmethylamine (NMEA)* N-Nitrosomorpholine (NMOR)* N-Nitrosopiperidine (NPIP)* N-Nitrosopyrrolidine (NPYR)* Disinfection By-Products Bromodichloromethane Dibromochloromethane Tribromomethane (Bromoform) Trichloromethane (Chloroform) Personal Care and Consumer Product Chemicals and Metabolites Benzophenone-3 Bisphenol A Bisphenol F* Bisphenol
    [Show full text]
  • DRAFT Indicators Biomonitoring: Perfluorochemicals (Pfcs)
    America’s Children and the Environment, Third Edition DRAFT Indicators Biomonitoring: Perfluorochemicals (PFCs) EPA is preparing the third edition of America’s Children and the Environment (ACE3), following the previous editions published in December 2000 and February 2003. ACE is EPA’s compilation of children’s environmental health indicators and related information, drawing on the best national data sources available for characterizing important aspects of the relationship between environmental contaminants and children’s health. ACE includes four sections: Environments and Contaminants, Biomonitoring, Health, and Special Features. EPA has prepared draft indicator documents for ACE3 representing 23 children's environmental health topics and presenting a total of 42 proposed children's environmental health indicators. This document presents the draft text, indicator, and documentation for the PFCs topic in the Biomonitoring section. THIS INFORMATION IS DISTRIBUTED SOLELY FOR THE PURPOSE OF PRE- DISSEMINATION PEER REVIEW UNDER APPLICABLE INFORMATION QUALITY GUIDELINES. IT HAS NOT BEEN FORMALLY DISSEMINATED BY EPA. IT DOES NOT REPRESENT AND SHOULD NOT BE CONSTRUED TO REPRESENT ANY AGENCY DETERMINATION OR POLICY. For more information on America’s Children and the Environment, please visit www.epa.gov/ace. For instructions on how to submit comments on the draft ACE3 indicators, please visit www.epa.gov/ace/ace3drafts/. March 2011 DRAFT: DO NOT QUOTE OR CITE Biomonitoring: Perfluorochemicals 1 Perfluorochemicals (PFCs) 2 3 Perfluorochemicals (PFCs) are a group of manmade chemicals that have been used since the 4 1950s in many consumer products.1 The structure of these chemicals makes them very stable, 5 hydrophobic (water-repelling), and oleophobic (oil-repelling).
    [Show full text]
  • And Polyfluoroalkyl Substances – Chemical Variation and Applicability of Current Fate Models
    CSIRO PUBLISHING Environ. Chem. 2020, 17, 498–508 Research Paper https://doi.org/10.1071/EN19296 Investigating the OECD database of per- and polyfluoroalkyl substances – chemical variation and applicability of current fate models Ioana C. Chelcea,A Lutz Ahrens,B Stefan O¨ rn,C Daniel MucsD and Patrik L. Andersson A,E ADepartment of Chemistry, Umea˚ University, SE-901 87 Umea˚, Sweden. BDepartment of Aquatic Sciences and Assessment, Swedish University of Agricultural Sciences (SLU), Box 7050, SE-750 07 Uppsala, Sweden. CDepartment of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences (SLU), SE-750 07 Uppsala, Sweden. DRISE SP – Chemical and Pharmaceutical Safety, Forskargatan 20, 151 36 So¨derta¨lje, Sweden. ECorresponding author. Email: [email protected] Environmental context. A diverse range of materials contain organofluorine chemicals, some of which are hazardous and widely distributed in the environment. We investigated an inventory of over 4700 organofluorine compounds, characterised their chemical diversity and selected representatives for future testing to fill knowledge gaps about their environmental fate and effects. Fate and property models were examined and concluded to be valid for only a fraction of studied organofluorines. Abstract. Many per- and polyfluoroalkyl substances (PFASs) have been identified in the environment, and some have been shown to be extremely persistent and even toxic, thus raising concerns about their effects on human health and the environment. Despite this, little is known about most PFASs. In this study, the comprehensive database of over 4700 PFAS entries recently compiled by the OECD was curated and the chemical variation was analysed in detail.
    [Show full text]
  • Cross-Sectional Study of the Association Between Serum Perfluorinated Alkyl Acid Concentrations and Dental Caries Among US Adolescents (NHANES 1999–2012)
    Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-024189 on 5 February 2019. Downloaded from Cross-sectional study of the association between serum perfluorinated alkyl acid concentrations and dental caries among US adolescents (NHANES 1999–2012) Nithya Puttige Ramesh,1 Manish Arora,2 Joseph M Braun1 To cite: Puttige Ramesh N, ABSTRACT Strengths and limitations of this study Arora M, Braun JM. Cross- Study objectives Perfluoroalkyl acids (PFAAs) are a class sectional study of the of anthropogenic and persistent compounds that may ► Our study contributes to a gap in the literature by association between serum impact some biological pathways related to oral health. perfluorinated alkyl acid examining the relationship between perfluoroalkyl The objective of our study was to estimate the relationship concentrations and dental caries acid exposure and dental caries prevalence among between dental caries prevalence and exposure to four among US adolescents (NHANES adolescents, which, to the best of our knowledge, PFAA: perfluorooctanoic acid (PFOA), perfluorononanoic 1999–2012). BMJ Open has not been examined before. 2019;9:e024189. doi:10.1136/ acid (PFNA), perfluorohexane sulfonic acid (PFHxS) and ► The strengths of our study include the large sample perfluorooctane sulfonic acid (PFOS) in a nationally bmjopen-2018-024189 size (2869 participants) and the nationally repre- representative sample of US adolescents. Prepublication history and sentative nature of the National Health and Nutrition ► Setting/Design We analysed cross-sectional data from additional material for this Examination Survey (NHANES). the National Health and Nutrition Examination Survey from paper are available online. To ► Although we adjusted for potential confounders, 1999 to 2012 for 12–19-year-old US adolescents.
    [Show full text]
  • PFAS MCL Technical Support Document
    ATTACHMENT 1 New Hampshire Department of Environmental Services Technical Background Report for the June 2019 Proposed Maximum Contaminant Levels (MCLs) and Ambient Groundwater Quality Standards (AGQSs) for Perfluorooctane sulfonic Acid (PFOS), Perfluorooctanoic Acid (PFOA), Perfluorononanoic Acid (PFNA), and Perfluorohexane sulfonic Acid (PFHxS) And Letter from Dr. Stephen M. Roberts, Ph.D. dated 6/25/2019 – Findings of Peer Review Conducted on Technical Background Report June 28, 2019 New Hampshire Department of Environmental Services Technical Background Report for the June 2019 Proposed Maximum Contaminant Levels (MCLs) and Ambient Groundwater Quality Standards (AGQSs) for Perfluorooctane sulfonic Acid (PFOS), Perfluorooctanoic Acid (PFOA), Perfluorononanoic Acid (PFNA), and Perfluorohexane sulfonic Acid (PFHxS) June 28, 2019 Table of Contents Abbreviations ................................................................................................................................................. i Acknowledgements ...................................................................................................................................... iii Section I. Executive Summary ....................................................................................................................... 1 Section II. Introduction ................................................................................................................................. 2 Section III. Reference Dose Derivation ........................................................................................................
    [Show full text]
  • Interplay Between Gating and Block of Ligand-Gated Ion Channels
    brain sciences Review Interplay between Gating and Block of Ligand-Gated Ion Channels Matthew B. Phillips 1,2, Aparna Nigam 1 and Jon W. Johnson 1,2,* 1 Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA; [email protected] (M.B.P.); [email protected] (A.N.) 2 Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA * Correspondence: [email protected]; Tel.: +1-(412)-624-4295 Received: 27 October 2020; Accepted: 26 November 2020; Published: 1 December 2020 Abstract: Drugs that inhibit ion channel function by binding in the channel and preventing current flow, known as channel blockers, can be used as powerful tools for analysis of channel properties. Channel blockers are used to probe both the sophisticated structure and basic biophysical properties of ion channels. Gating, the mechanism that controls the opening and closing of ion channels, can be profoundly influenced by channel blocking drugs. Channel block and gating are reciprocally connected; gating controls access of channel blockers to their binding sites, and channel-blocking drugs can have profound and diverse effects on the rates of gating transitions and on the stability of channel open and closed states. This review synthesizes knowledge of the inherent intertwining of block and gating of excitatory ligand-gated ion channels, with a focus on the utility of channel blockers as analytic probes of ionotropic glutamate receptor channel function. Keywords: ligand-gated ion channel; channel block; channel gating; nicotinic acetylcholine receptor; ionotropic glutamate receptor; AMPA receptor; kainate receptor; NMDA receptor 1. Introduction Neuronal information processing depends on the distribution and properties of the ion channels found in neuronal membranes.
    [Show full text]
  • Us 2018 / 0296525 A1
    UN US 20180296525A1 ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2018/ 0296525 A1 ROIZMAN et al. ( 43 ) Pub . Date: Oct. 18 , 2018 ( 54 ) TREATMENT OF AGE - RELATED MACULAR A61K 38 /1709 ( 2013 .01 ) ; A61K 38 / 1866 DEGENERATION AND OTHER EYE (2013 . 01 ) ; A61K 31/ 40 ( 2013 .01 ) DISEASES WITH ONE OR MORE THERAPEUTIC AGENTS (71 ) Applicant: MacRegen , Inc ., San Jose , CA (US ) (57 ) ABSTRACT ( 72 ) Inventors : Keith ROIZMAN , San Jose , CA (US ) ; The present disclosure provides therapeutic agents for the Martin RUDOLF , Luebeck (DE ) treatment of age - related macular degeneration ( AMD ) and other eye disorders. One or more therapeutic agents can be (21 ) Appl. No .: 15 /910 , 992 used to treat any stages ( including the early , intermediate ( 22 ) Filed : Mar. 2 , 2018 and advance stages ) of AMD , and any phenotypes of AMD , including geographic atrophy ( including non -central GA and Related U . S . Application Data central GA ) and neovascularization ( including types 1 , 2 and 3 NV ) . In certain embodiments , an anti - dyslipidemic agent ( 60 ) Provisional application No . 62/ 467 ,073 , filed on Mar . ( e . g . , an apolipoprotein mimetic and / or a statin ) is used 3 , 2017 . alone to treat or slow the progression of atrophic AMD Publication Classification ( including early AMD and intermediate AMD ) , and / or to (51 ) Int. CI. prevent or delay the onset of AMD , advanced AMD and /or A61K 31/ 366 ( 2006 . 01 ) neovascular AMD . In further embodiments , two or more A61P 27 /02 ( 2006 .01 ) therapeutic agents ( e . g ., any combinations of an anti - dys A61K 9 / 00 ( 2006 . 01 ) lipidemic agent, an antioxidant, an anti- inflammatory agent, A61K 31 / 40 ( 2006 .01 ) a complement inhibitor, a neuroprotector and an anti - angio A61K 45 / 06 ( 2006 .01 ) genic agent ) that target multiple underlying factors of AMD A61K 38 / 17 ( 2006 .01 ) ( e .
    [Show full text]
  • And Polyfluoroalkyl Substances at a Contaminated Fire Training Facility To
    Subscriber access provided by ECCC Library Services / Accès fournit par les Service de bibliothèque d'ECCC Article Plant uptake of per- and polyfluoroalkyl substances at a contaminated fire training facility to evaluate the phytoremediation potential of various plant species Laura Gobelius, Jeffrey Lewis, and Lutz Ahrens Environ. Sci. Technol., Just Accepted Manuscript • DOI: 10.1021/acs.est.7b02926 • Publication Date (Web): 03 Oct 2017 Downloaded from http://pubs.acs.org on October 19, 2017 Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
    [Show full text]
  • Planning for Tourism and Outdoor Recreation in the Blekinge Archipelago, Sweden
    WP 2009:1 Zoning in a future coastal biosphere reserve - Planning for tourism and outdoor recreation in the Blekinge archipelago, Sweden Rosemarie Ankre WORKING PAPER www.etour.se Zoning in a future coastal biosphere reserve Planning for tourism and outdoor recreation in the Blekinge archipelago, Sweden Rosemarie Ankre TABLE OF CONTENTS PREFACE………………………………………………..…………….………………...…..…..5 1. BACKGROUND………………………………………………………………………………6 1.1 Introduction……………………………………………………………………………….…6 1.2 Geographical and historical description of the Blekinge archipelago……………...……6 2. THE DATA COLLECTION IN THE BLEKINGE ARCHIPELAGO 2007……….……12 2.1 The collection of visitor data and the variety of methods ………………………….……12 2.2 The method of registration card data……………………………………………………..13 2.3 The applicability of registration cards in coastal areas……………………………….…17 2.4 The questionnaire survey ………………………………………………………….....……21 2.5 Non-response analysis …………………………………………………………………..…25 3. RESULTS OF THE QUESTIONNAIRE SURVEY IN THE BLEKINGE ARCHIPELAGO 2007………………………………………………………………..…..…26 3.1 Introduction…………………………………………………………………………...……26 3.2 Basic information of the respondents………………………………………………..……26 3.3 Accessibility and means of transport…………………………………………………...…27 3.4 Conflicts………………………………………………………………………………..……28 3.5 Activities……………………………………………………………………………....…… 30 3.6 Experiences of existing and future developments of the area………………...…………32 3.7 Geographical dispersion…………………………………………………………...………34 3.8 Access to a second home…………………………………………………………..……….35 3.9 Noise
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen Et Al
    USOO8603526B2 (12) United States Patent (10) Patent No.: US 8,603,526 B2 Tygesen et al. (45) Date of Patent: Dec. 10, 2013 (54) PHARMACEUTICAL COMPOSITIONS 2008. O152595 A1 6/2008 Emigh et al. RESISTANT TO ABUSE 2008. O166407 A1 7/2008 Shalaby et al. 2008/0299.199 A1 12/2008 Bar-Shalom et al. 2008/0311205 A1 12/2008 Habib et al. (75) Inventors: Peter Holm Tygesen, Smoerum (DK); 2009/0022790 A1 1/2009 Flath et al. Jan Martin Oevergaard, Frederikssund 2010/0203129 A1 8/2010 Andersen et al. (DK); Karsten Lindhardt, Haslev (DK); 2010/0204259 A1 8/2010 Tygesen et al. Louise Inoka Lyhne-versen, Gentofte 2010/0239667 A1 9/2010 Hemmingsen et al. (DK); Martin Rex Olsen, Holbaek 2010, O291205 A1 11/2010 Downie et al. (DK); Anne-Mette Haahr, Birkeroed 2011 O159100 A1 6/2011 Andersen et al. (DK); Jacob Aas Hoellund-Jensen, FOREIGN PATENT DOCUMENTS Frederikssund (DK); Pemille Kristine Hoeyrup Hemmingsen, Bagsvaerd DE 20 2006 014131 1, 2007 (DK) EP O435,726 8, 1991 EP O493513 7, 1992 EP O406315 11, 1992 (73) Assignee: Egalet Ltd., London (GB) EP 1213014 6, 2002 WO WO 89,09066 10, 1989 (*) Notice: Subject to any disclaimer, the term of this WO WO91,040 15 4f1991 patent is extended or adjusted under 35 WO WO95/22962 8, 1995 U.S.C. 154(b) by 489 days. WO WO99,51208 10, 1999 WO WOOOf 41704 T 2000 WO WO 03/024426 3, 2003 (21) Appl. No.: 12/701,429 WO WOO3,O24429 3, 2003 WO WOO3,O24430 3, 2003 (22) Filed: Feb.
    [Show full text]
  • Småland‑Blekinge 2019 Monitoring Progress and Special Focus on Migrant Integration
    OECD Territorial Reviews SMÅLAND-BLEKINGE OECD Territorial Reviews Reviews Territorial OECD 2019 MONITORING PROGRESS AND SPECIAL FOCUS ON MIGRANT INTEGRATION SMÅLAND-BLEKINGE 2019 MONITORING PROGRESS AND PROGRESS MONITORING SPECIAL FOCUS ON FOCUS SPECIAL MIGRANT INTEGRATION MIGRANT OECD Territorial Reviews: Småland‑Blekinge 2019 MONITORING PROGRESS AND SPECIAL FOCUS ON MIGRANT INTEGRATION This document, as well as any data and any map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area. Please cite this publication as: OECD (2019), OECD Territorial Reviews: Småland-Blekinge 2019: Monitoring Progress and Special Focus on Migrant Integration, OECD Territorial Reviews, OECD Publishing, Paris. https://doi.org/10.1787/9789264311640-en ISBN 978-92-64-31163-3 (print) ISBN 978-92-64-31164-0 (pdf) Series: OECD Territorial Reviews ISSN 1990-0767 (print) ISSN 1990-0759 (online) The statistical data for Israel are supplied by and under the responsibility of the relevant Israeli authorities. The use of such data by the OECD is without prejudice to the status of the Golan Heights, East Jerusalem and Israeli settlements in the West Bank under the terms of international law. Photo credits: Cover © Gabriella Agnér Corrigenda to OECD publications may be found on line at: www.oecd.org/about/publishing/corrigenda.htm. © OECD 2019 You can copy, download or print OECD content for your own use, and you can include excerpts from OECD publications, databases and multimedia products in your own documents, presentations, blogs, websites and teaching materials, provided that suitable acknowledgement of OECD as source and copyright owner is given.
    [Show full text]
  • Biogas Production Using Sludge from Small Scale Sewage Plants a Feasibility Study in Ronneby Municipality
    Bi oga s pr oduct ion using sludge from small scale sewage plants REPORT 4.2.3 MOMENT | REPORT BIOGAS FEASIBILITY Title Biogas production using sludge from small scale sewage plants a feasibility study in Ronneby municipality Author(s) Catarina Welin Date 2011 MOMENT Partner(s) Municipality of Ronneby Editors Tobias Facchini Stan Weyns 3 MOMENT | REPORT BIOGAS FEASIBILITY TABLE OF CONTENT ABOUT PROJECT MOMENT .................................................................................. 6 Contact us ......................................................................................................................... 6 ABSTRACT .............................................................................................................. 7 INTRODUCTION ..................................................................................................... 8 OBJECTIVES ........................................................................................................... 9 METHOD ................................................................................................................. 9 The study area .................................................................................................................. 9 Sewer inventory .............................................................................................................. 10 FEASIBILITY STUDY ON BIOGAS ....................................................................... 13 Anaerobic digestion - a microbiological process ............................................................
    [Show full text]